For the year ending 2025-12-31, ZNTL has $288,967K in assets. $72,763K in debts. $35,995K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 35,995 | |||
| Marketable debt securities, available for sale | 209,898 | |||
| Marketable equity securities | 0 | |||
| Contracts receivable | 0 | |||
| Prepaid expenses and other current assets | 7,298 | |||
| Total current assets | 253,191 | |||
| Property and equipment, net | 2,770 | |||
| Operating lease right-of-use assets | 26,271 | |||
| Prepaid expenses and other assets | 4,108 | |||
| Restricted cash | 2,627 | |||
| Total assets | 288,967 | |||
| Accounts payable | 7,208 | |||
| Accrued expenses | 29,351 | |||
| Total current liabilities | 36,559 | |||
| Long-term lease liability | 35,704 | |||
| Other long-term liabilities | 500 | |||
| Total liabilities | 72,763 | |||
| Common stock, 0.001 par value 250,000,000 shares authorized 69,085,980 and 71,282,400 shares issued and outstanding at december31, 2025 and 2024, respectively | 69 | |||
| Additional paid-in capital | 1,407,394 | |||
| Accumulated other comprehensive income | 196 | |||
| Accumulated deficit | -1,191,455 | |||
| Total stockholders' equity | 216,204 | |||
| Total liabilities and stockholders' equity | 288,967 | |||
Zentalis Pharmaceuticals, Inc. (ZNTL)
Zentalis Pharmaceuticals, Inc. (ZNTL)